Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor

Virology

Volumn 328, Issue 2, 2004, Pages 163-168

  Schäfer, Alexandra ^a   Bogerd, Hal P ^a   Cullen, Bryan R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

APOBEC3G; HIV 1; RNA binding; Virion incorporation

Indexed keywords

GAG PROTEIN; NUCLEOCAPSID PROTEIN; POLYPROTEIN; PROTEIN PRECURSOR; RNA; VIF PROTEIN; VIRUS PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RNA BINDING; VIRION; VIRUS NUCLEOCAPSID; WESTERN BLOTTING;

CELL LINE, TRANSFORMED; GENE PRODUCTS, GAG; GENE PRODUCTS, VIF; HIV-1; NUCLEOCAPSID; NUCLEOSIDE DEAMINASES; PROTEIN PRECURSORS; PROTEIN STRUCTURE, TERTIARY; PROTEINS; REPRESSOR PROTEINS; RNA, VIRAL; VIRION; VIRUS ASSEMBLY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 5344222683     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.08.006     Document Type: Article

References (20)

1. M.A. Accola, B. Strack, and H.G. Göttlinger Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 Capsid-p2 and a late assembly domain J. Virol. 74 2000 5395 5402
2. H.P. Bogerd, B.P. Doehle, H.L. Wiegand, and B.R. Cullen A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV-1 Vif Proc. Natl. Acad. Sci. U.S.A. 101 2004 3770 3774
3. S. Cen, F. Guo, M. Niu, J. Saadatmand, J. Deflassieux, and L. Kleiman The interaction between HIV-1 Gag and APOBEC3G J. Biol. Chem. 279 2004 33177 33184
4. B. Chesebro, K. Wehrly, J. Nishio, and S. Perryman Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism J. Virol. 66 1992 6547 6554
5. S.G. Conticello, R.S. Harris, and M.S. Neuberger The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G Curr. Biol. 13 2003 2009 2013
6. S. Cowan, T. Hatziioannou, T. Cunningham, M.A. Muesing, H.G. Gottlinger, and P.D. Bieniasz Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism Proc. Natl. Acad. Sci. U.S.A. 99 2002 11914 11919
7. T. Dorfman, J. Luban, S.P. Goff, W.A. Haseltine, and H.G. Göttlinger Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein J. Virol. 67 1993 6159 6169
8. R.J. Gorelick, D.J. Chabot, A. Rein, L.E. Henderson, and L.O. Arthur The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent J. Virol. 67 1993 4027 4036
9. R.S. Harris, K.N. Bishop, A.M. Sheehy, H.M. Craig, S.K. Petersen-Mahrt, I.N. Watt, M.S. Neuberger, and M.H. Malim DNA deamination mediates innate immunity to retroviral infection Cell 113 2003 803 809
10. B. Mangeat, P. Turelli, G. Caron, M. Friedli, L. Perrin, and D. Trono Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts Nature 424 2003 99 103
11. R. Mariani, D. Chen, B. Schröfelbauer, F. Navarro, R. König, B. Bollman, C. Münk, H. Nymark-McMahon, and N.R. Landau Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif Cell 114 2003 21 31
12. M. Marin, K.M. Rose, S.L. Kozak, and D. Kabat HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation Nat. Med. 9 2003 1398 1403
13. R.H. Oakley, S.A. Laporte, J.A. Holt, M.G. Caron, and L.S. Barak Differential affinities of visual arrestin, βarrestin1, and βarrestin2 for G protein-coupled receptors delineate two major classes of receptors J. Biol. Chem. 275 2000 17201 17210
14. D.A. Rubinson, C.P. Dillon, A.V. Kwiatkowski, C. Sievers, L. Yang, J. Kopinja, M. Zhang, M.T. McManus, F.B. Gertler, M.L. Scott, and L. Van Parijs A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference Nat. Genet. 33 2003 401 406
15. A.M. Sheehy, N.C. Gaddis, and M.H. Malim The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif Nat. Med. 9 2003 1404 1407
16. K. Stopak, C. de Noronha, W. Yonemoto, and W.C. Greene HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability Mol. Cell 12 2003 591 601
17. E.S. Svarovskaia, H. Xu, J.L. Mbisa, R. Barr, R.J. Gorelick, A. Ono, E.O. Freed, W.-S. Hu, and V.K. Pathak Human APOBEC3G is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs J. Biol. Chem. 279 2004 35822 35828
18. Q. Yu, R. König, S. Pillai, K. Chiles, M. Kearney, S. Palmer, D. Richman, J.M. Coffin, and N.R. Landau Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome Nat. Struct. Mol. Biol. 11 2004 435 442
19. X. Yu, Y. Yu, B. Liu, K. Luo, W. Kong, P. Mao, and X.-F. Yu Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex Science 302 2003 1056 1060
20. H. Zhang, B. Yang, R.J. Pomerantz, C. Zhang, S.C. Arunachalam, and L. Gao The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA Nature 424 2003 94 98